Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor

Immunology

Volumn 77, Issue 4, 1992, Pages 510-514

  Piguet, P F ^a   Grau, G E ^a   Vesin, C ^a   Loetscher, H ^a   Gentz, R ^a   Lesslauer, W ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 2; FREUND ADJUVANT; LYMPHOTOXIN RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ARTHRITIS; AUTOANTIBODIES; COLLAGEN; FOOT; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED DBA; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0026677361     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)